141 related articles for article (PubMed ID: 31287423)
1. Age cutoff for reporting of benign-appearing endometrial cells in Papanicolaou specimens; should it be raised? A 10-year retrospective study from a large county hospital.
Hinson S; Molberg K; Mir M; Flores M; Zheng W; Lucas E
J Am Soc Cytopathol; 2019; 8(2):78-83. PubMed ID: 31287423
[TBL] [Abstract][Full Text] [Related]
2. Reporting of Benign Endometrial Cells in Papanicolaou Tests.
Hernandez A; Schatz-Siemers N; Zhou F; Brandler TC; Negron R; Modi L; Elgert PA; Simsir A
Am J Clin Pathol; 2020 Aug; 154(3):381-386. PubMed ID: 32405650
[TBL] [Abstract][Full Text] [Related]
3. Significance of atypical endometrial cells in women younger than 40 years of age.
Yuan L; Biscotti CV; Zhu H; Booth CN; Abdul-Karim FW; Zhang Y
J Am Soc Cytopathol; 2020; 9(1):33-37. PubMed ID: 31353256
[TBL] [Abstract][Full Text] [Related]
4. Normal-Appearing Endometrial Cells in Pap Tests of Women Aged Forty Years or Older and Cytohistological Correlates.
Izadi-Mood N; Sarmadi S; Sanii S; Sadidi H
Acta Cytol; 2015; 59(2):175-9. PubMed ID: 25924690
[TBL] [Abstract][Full Text] [Related]
5. Age cut-off for reporting endometrial cells on a Papanicolaou test: 50 years may be more appropriate than 45 years.
Weiss VL; Cate F; Bloom L; Fadare O; Coogan AC; Desouki MM
Cytopathology; 2016 Aug; 27(4):242-8. PubMed ID: 26689647
[TBL] [Abstract][Full Text] [Related]
6. In Papanicolaou smears, benign appearing endometrial cells bear no significance in predicting uterine endometrial adenocarcinomas.
Moatamed NA; Le LT; Levin MR; Govind R; Apple SK
Diagn Cytopathol; 2013 Apr; 41(4):335-41. PubMed ID: 22102567
[TBL] [Abstract][Full Text] [Related]
7. Normal endometrial cells in Papanicolaou smears: prevalence in women with and without endometrial disease.
Gomez-Fernandez CR; Ganjei-Azar P; Behshid K; Averette HE; Nadji M
Obstet Gynecol; 2000 Dec; 96(6):874-8. PubMed ID: 11084170
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the Age Cutoff Criterion for Reporting Benign-Appearing Endometrial Cells in Routine Pap Tests: An 8-Year Retrospective Review.
Grada Z; Paquette C; Eklund CM; Zhang C; Sung CJ; Steinhoff M; Quddus MR
Acta Cytol; 2017; 61(3):194-198. PubMed ID: 28486237
[TBL] [Abstract][Full Text] [Related]
9. The Bethesda System 2001 recommendation for reporting of benign appearing endometrial cells in Pap tests of women age 40 years and older leads to unwarranted surveillance when followed without clinical qualifiers.
Aslan DL; Crapanzano JP; Harshan M; Erroll M; Vakil B; Pirog EC
Gynecol Oncol; 2007 Oct; 107(1):86-93. PubMed ID: 17604086
[TBL] [Abstract][Full Text] [Related]
10. Long-term clinical significance of benign endometrial cells identified on routine cervical cytology in women aged more or equal to 45 years.
Carpentier J; Sahebali S; Degaillier C; De Sutter P; Cosyns S
J Am Soc Cytopathol; 2023; 12(6):469-475. PubMed ID: 37689548
[TBL] [Abstract][Full Text] [Related]
11. Negative Predictive Value and Significance of Benign-Appearing Endometrial Cells in Papanicolaou Tests.
Yu J; Onisko A; Austin RM
Am J Clin Pathol; 2017 Sep; 148(3):274-279. PubMed ID: 28821196
[TBL] [Abstract][Full Text] [Related]
12. Liquid-based Papanicolaou test (SurePath) interpretations before histologic diagnosis of endometrial hyperplasias and carcinomas: study of 272 cases classified by the 2001 Bethesda system.
Thrall M; Kjeldahl K; Gulbahce HE; Pambuccian SE
Cancer; 2007 Aug; 111(4):217-23. PubMed ID: 17599738
[TBL] [Abstract][Full Text] [Related]
13. Atypical glandular cells of undetermined significance favor endometrial origin. Criteria for separating low grade endometrial adenocarcinoma from benign endometrial lesions.
Salomão DR; Hughes JH; Raab SS
Acta Cytol; 2002; 46(3):458-64. PubMed ID: 12040637
[TBL] [Abstract][Full Text] [Related]
14. Significant increase of benign endometrial cells on Papanicolaou smears in women using hormone replacement therapy.
Mount SL; Wegner EK; Eltabbakh GH; Olmstead JI; Drejet AE
Obstet Gynecol; 2002 Sep; 100(3):445-50. PubMed ID: 12220762
[TBL] [Abstract][Full Text] [Related]
15. Significance of endometrial cells in cervical cytology.
Yu EJ; Park NH; Song YS; Lee YK
J Obstet Gynaecol; 2016 Oct; 36(7):966-969. PubMed ID: 27560859
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of a cytologic diagnosis of atypical glandular cells, favor endometrial origin, in Pap smears.
Saad RS; Takei H; Liu YL; Silverman JE; Lipscomb JT; Ruiz B
Acta Cytol; 2006; 50(1):48-54. PubMed ID: 16514840
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of benign endometrial cells in postmenopausal women.
Ashfaq R; Sharma S; Dulley T; Saboorian MH; Siddiqui MT; Warner C
Diagn Cytopathol; 2001 Oct; 25(4):235-8. PubMed ID: 11599107
[TBL] [Abstract][Full Text] [Related]
18. Change of Practice Patterns Following an Educational Comment on Reports of Benign-Appearing Endometrial Cells in Papanicolaou Tests.
Jones TE; Onisko A; Austin RM; Yu J
Am J Clin Pathol; 2022 Mar; 157(3):413-416. PubMed ID: 34528660
[TBL] [Abstract][Full Text] [Related]
19. Incidence and clinical significance of morphologically benign-appearing endometrial cells in patients age 40 years or older: the impact of the 2001 Bethesda System.
Bean SM; Connolly K; Roberson J; Eltoum I; Chhieng DC
Cancer; 2006 Feb; 108(1):39-44. PubMed ID: 16329117
[TBL] [Abstract][Full Text] [Related]
20. Routine endometrial sampling of asymptomatic premenopausal women shedding normal endometrial cells in Papanicolaou tests is not cost effective.
Kapali M; Agaram NP; Dabbs D; Kanbour A; White S; Austin RM
Cancer; 2007 Feb; 111(1):26-33. PubMed ID: 17262796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
